Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute USD Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Therapy Type

  2.3.2 Market Size By Service Type

  2.3.3 Market Size By Indication

 2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Materials, Cell Culture Media & Vector Component Suppliers

  3.4.2 ATMP CDMOs, Process Development & Manufacturing Providers

  3.4.3 Cold Chain Logistics, Testing Laboratories & Distribution Partners

  3.4.4 Biopharma Companies, Research Institutes & Healthcare Providers

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

  4.1 Manufacturing Capacity and Operational Metrics

4.1.1 Manufacturing batch throughput and production capacity utilization across ATMP facilities
4.1.2 Average production turnaround time for cell and gene therapy manufacturing projects
4.1.3 Facility utilization and cleanroom operational efficiency metrics
4.1.4 Manufacturing success rates across autologous and allogeneic therapy production processes

4.2 Process Quality and Regulatory Compliance Metrics

4.2.1 Batch release success and quality assurance performance indicators
4.2.2 Process deviation and contamination incidence rates in ATMP manufacturing operations
4.2.3 Regulatory inspection readiness and compliance performance metrics
4.2.4 Process consistency and product reproducibility across manufacturing campaigns

4.3 Supply Chain and Commercialization Metrics

4.3.1 Chain-of-identity and chain-of-custody management performance indicators
4.3.2 Manufacturing-to-patient delivery turnaround efficiency metrics
4.3.3 Technology transfer success rates between therapy developers and CDMOs
4.3.4 Commercial-scale manufacturing readiness and capacity expansion indicators

4.4 Technology and Innovation Trend Metrics

4.4.1 Adoption trend of automated and closed-system ATMP manufacturing platforms
4.4.2 Penetration trend of digital manufacturing and real-time process monitoring technologies
4.4.3 Integration trend of AI-driven analytics in ATMP process development and optimization
4.4.4 Innovation trend toward scalable, modular, and next-generation cell and gene therapy manufacturing systems

5. Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmental Analysis & Forecast, By Therapy Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Cell Therapy

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Gene Therapy

 5.4 Tissue-Engineered Products

 5.5 Combined ATMPs

6. Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmental Analysis & Forecast, By Service Type, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Process Development

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Manufacturing Services

 6.4 Analytical & Quality Control Services

 6.5 Fill-Finish Services

 6.6 Regulatory Support Services

7. Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmental Analysis & Forecast, By Indication, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Oncology

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Rare Genetic Disorders

 7.4 Cardiovascular Diseases

 7.5 Neurological Disorders

 7.6 Other Therapeutic Areas

8. Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Biopharmaceutical Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Emerging Biotechnology Companies

 8.4 Academic & Research Institutes

 8.5 Healthcare Organizations

9. Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Therapy Type, 2022–2035

 9.2.3 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.2.4 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Indication, 2022–2035

 9.2.5 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By End User, 2022–2035

 9.2.6 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Therapy Type, 2022–2035

 9.3.3 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.3.4 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Indication, 2022–2035

 9.3.5 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By End User, 2022–2035

 9.3.6 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Therapy Type, 2022–2035

 9.4.3 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.4.4 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Indication, 2022–2035

 9.4.5 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By End User, 2022–2035

 9.4.6 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Therapy Type, 2022–2035

 9.5.3 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.5.4 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Indication, 2022–2035

 9.5.5 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By End User, 2022–2035

 9.5.6 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Therapy Type, 2022–2035

 9.6.3 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Service Type, 2022–2035

 9.6.4 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Indication, 2022–2035

 9.6.5 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By End User, 2022–2035

 9.6.6 Advanced Therapy Medicinal Products (ATMP) CDMO Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Lonza Group AG

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

10.6.2 Catalent, Inc.

10.6.3 Thermo Fisher Scientific Inc.

10.6.4 Charles River Laboratories International, Inc.

10.6.5 WuXi Advanced Therapies

10.6.6 Fujifilm Diosynth Biotechnologies

10.6.7 Samsung Biologics Co., Ltd.

10.6.8 AGC Biologics

10.6.9 Cytiva

10.6.10 Recipharm AB

10.6.11 Oxford Biomedica plc

10.6.12 Viralgen Vector Core

10.6.13 Cell and Gene Therapy Catapult

10.6.14 RoslinCT

10.6.15 Miltenyi Biotec

10.6.16 Minaris Regenerative Medicine

10.6.17 Rentschler Biopharma SE

10.6.18 Yposkesi

10.6.19 Takara Bio Inc.

10.6.20 Genezen Laboratories

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures